Walgreens (NYSE:WAG) reported its results for the fourth quarter. Net income for the drug store rose to $792 million (87 cents per share) vs. $470 million (48 cents per share) in the same quarter a year earlier. This marks a rise of 68.5% from the year earlier quarter. Revenue rose 6.5% to $17.97 billion from the year earlier quarter. WAG reported adjusted net income of 57 cents per share. By that measure, the company beat the mean estimate of 55 cents per share. Analysts were expecting revenue of $17.88 billion.
“Walgreens delivered strong performance and growth for the quarter and the year by continuing our relentless focus on providing convenience and value to consumers, and cost-effective pharmacy, health and wellness solutions to the millions of patients we serve every day,” said Walgreens President and CEO Greg Wasson. “Through constant innovation and effective execution of our key initiatives, we continued to make substantial progress this year in the transformation of Walgreens to become the first choice for health and daily living – meeting the needs of both consumers and patients in today’s challenging economy and changing health care system.”
Competitors to Watch: drugstore.com, inc. (NASDAQ:DSCM), Graymark Healthcare Inc (NASDAQ:GRMH), CVS Caremark Corporation (NYSE:CVS), Rite Aid Corporation (NYSE:RAD), PetMed Express, Inc. (NASDAQ:PETS), China Nepstar Chain Drugstore Ltd. (NYSE:NPD), Target (NYSE:TGT), PharMerica Corporation (NYSE:PMC), Walmart (NYSE:WMT), BioScrip Inc. (NASDAQ:BIOS), and Medco Health Solutions Inc. (NYSE:MHS).
Accenture (NYSE:ACN) reported higher profit for the fourth quarter as revenue showed growth. Net income for Accenture plc rose to $611.9 million (91 cents per share) vs. $445.5 million (66 cents per share) in the same quarter a year earlier. This marks a rise of 37.4% from the year earlier quarter. Revenue rose 23% to $7.17 billion from the year earlier quarter. ACN beat the mean analyst estimate of 89 cents per share. It beat the average revenue estimate of $6.5 billion.
Accenture’s Board of Directors has declared a semi-annual cash dividend of 67.5 cents per share, an increase of 22.5 cents per share, or 50 percent, over its previous semi-annual dividend, declared in March. The Board also approved $5 billion in additional share repurchase authority. Pierre Nanterme, Accenture’s chief executive officer, said, “Our excellent results for the fourth quarter and full fiscal 2011 reflect the continued momentum in our business as we execute our growth strategy. We hit the top end of our range for both revenues and EPS and are particularly pleased with the growth across all dimensions of our business. In addition, we generated free cash flow of $3 billion for the year, which enabled us to return more than $2.8 billion to our shareholders through dividends and share repurchases and still close the year with an exceptionally strong balance sheet.”
Competitors to Watch: Intl. Business Machines Corp. (NYSE:IBM), Oracle Corporation (NASDAQ:ORCL), Genpact Limited (NYSE:G), Microsoft Corporation (NASDAQ:MSFT), Hewlett-Packard Company (NYSE:HPQ), Towers Watson & Co (NYSE:TW), Infosys Tech. Ltd. (NASDAQ:INFY), Wipro Limited (NYSE:WIT), Ariba, Inc. (NASDAQ:ARBA).